Metastatic Breast Cancer HR+, HER2-
Also known as: Metastatic HR+ HER2- breast cancer / HR+ HER2- metastatic breast cancer / Metastatic HR + HER2 - breast cancer
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB12001 | Abemaciclib | A medication used to treat HR+ HER2- advanced or metastatic breast cancer. |
| DB12015 | Alpelisib | Alpelisib is indicated in combination with fulvestrant to treat postmenopausal women, and men, with advanced or metastatic breast cancer. This cancer must be hormone receptor (HR)-positive, human epidermal growth factor... |
| DB01006 | Letrozole | An aromatase inhibitor used to treat breast cancer in postmenopausal women. |
| Drug | Drug Name | Phase | Status | Count |
|---|